Rose Therapeutics reported raising $650,000 in an initial SEC Form D filing, from an offering of $1 Million
Round Type
Seed
Quick answer
Rose Therapeutics raised $650,000 in a Seed round, dated August 22, 2022. Rose Therapeutics is based in Norristown, Pennsylvania, United States.
- How much did Rose Therapeutics raise?
- Rose Therapeutics raised $650,000 in a Seed round on August 22, 2022.
- Where is Rose Therapeutics based and how big is it?
- Rose Therapeutics is based in Norristown, Pennsylvania, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Rose Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Blaze Bioscience raised $25M on October 6, 2022.
- Werewool raised $450K (Seed) on October 6, 2022.
- Genetesis raised $18M (Series C) on October 6, 2022.
- Covira raised an undisclosed amount (Funding Round) on October 6, 2022.
- Inanovate raised $2.4M (Seed) on October 5, 2022.
- Valitor raised an undisclosed amount (Series B) on October 5, 2022.
Who to call at Rose Therapeutics, and when
A new round usually means Rose Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rose Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rose Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rose Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rose Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Rose Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.